Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-12-23

Clinical Trial Update: Vitamin D and Carboxy PTH Fragments in Coronary Calcification [Phase 4]

View source ↗

Summary

Phase 4 trial assessing vitamin D and carboxy PTH fragments for coronary calcification has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Southeast Renal Research Institute | Conditions: Coronary Calcification, Endstage Renal Disease | Phase 4 | Status: WITHDRAWN